Isolation and Analysis of Traceable and Functionalized Extracellular Vesicles from the Plasma and Solid Tissues
October 17th, 2022
The present protocol describes a method to extract extracellular vesicles from the peripheral blood and solid tissues with subsequent profiling of surface antigens and protein cargos.
Overview
This study presents a protocol for the extraction of extracellular vesicles (EVs) from peripheral blood and solid tissues, allowing for the profiling of surface antigens and protein components. The method enhances the quality and yield of EVs suitable for further functional analysis, particularly in the context of physiological and pathological studies.
Key Study Components
Research Area
- Extracellular vesicle biology
- Diagnostic applications in cancer and inflammatory diseases
- Sample preparation and analysis methods
Background
- Importance of extracellular vesicles in cell communication
- Need for reliable methods to isolate EVs for analysis
- Role of surface markers in disease diagnosis
Methods Used
- Isolation of EVs from blood and solid tissues
- Flow cytometry for profiling surface antigens
- BCA protein assay for quantifying protein content
Main Results
- Successfully isolated high-quality EVs with minimal contamination
- Identified surface markers relevant to bone and cancer pathology
- Demonstrated the feasibility of using this method in diagnostic settings
Conclusions
- The study demonstrates a robust method for EV extraction and characterization.
- This protocol has significant implications for biological research and clinical diagnostics.
Frequently Asked Questions
Executive Industry Relevance
Reliable isolation and profiling of extracellular vesicles (EVs) from plasma and solid tissues enables mechanistic de-risking and target validation in early discovery and translational research. Quantitative analysis of EV surface antigens and protein cargo supports predictive confidence for biomarker development and disease mechanism studies. This workflow strengthens portfolio decisions by providing standardized, reproducible EV characterization across diverse biological contexts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of EV origin and molecular cargo for functional target validation.
- Supports mechanistic de-risking by linking EV markers to parent cell types and disease states.
- Facilitates predictive confidence in biomarker identification for portfolio triage.
Screening & Assay Development
- Prepares validated EV samples for downstream flow cytometry and protein analysis workflows.
- Standardizes EV isolation and quantification, improving assay reproducibility and comparability.
- Enables quantitative measurement of surface antigens and protein content for screening readiness.
Translational & Preclinical Research
- Aligns EV marker profiles with disease-relevant systems for translational biomarker studies.
- Provides continuity from discovery through preclinical validation by enabling functional and mechanistic EV analysis.
- Supports risk-adjusted advancement decisions based on quantitative EV characterization.
Pipeline & Workflow Integration
This EV isolation and analysis protocol integrates from early discovery through preclinical research, supporting hypothesis testing, biomarker validation, and mechanistic studies.
- Discovery Biology: Enables hypothesis-driven analysis of EV origin, cargo, and function for pathway clarification.
- Screening: Provides standardized, reproducible EV samples and quantitative readouts for assay development.
- Analytics: Delivers flow cytometry and protein quantification outputs for robust condition comparison.
- Translational Research: Connects EV marker profiles to disease models and biomarker alignment.
- Enterprise Reuse: Establishes a reusable, scalable protocol for EV analysis across multiple R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in EV-based studies.
- Operational Value: Delivers standardized, reproducible, and scalable EV isolation and analysis workflows.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling robust biomarker and mechanistic studies.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of EV-related discovery programs.
Implementation Considerations
- Requires expertise in tissue processing, flow cytometry, and protein analysis.
- Needs access to centrifugation, flow cytometry, and protein quantification instrumentation.
- Demands cross-team standardization for sample preparation and data analysis.
- Adaptable to various tissue types but may require optimization for specific models.
- Sample yield and purity depend on careful execution of tissue digestion and centrifugation steps.
Biopharma FAQs
Chapters in this video
0:05
Introduction
1:20
Preparation of the Plasma and the Maxillary Bone Samples and Extraction of Extracellular Vesicles
2:50
Origin Analysis of Extracellular Vesicles
5:17
Protein Content Analysis of Extracellular Vesicles
8:06
Results: Profiling of Surface Antigens and Protein Cargos of Extracellular Vesicles Isolated from In Vivo Samples
9:13
Conclusion
